Indiana University Health
14
3M
14
0.56
1
- Areas of investment
Summary
The main office of represented Corporate Investor is situated in the Indianapolis. The venture was found in North America in United States.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Indiana University Health, startups are often financed by Sanderling Ventures, River Cities Capital Funds, Triathlon Medical Venture Partners. The meaningful sponsors for the fund in investment in the same round are Triathlon Medical Venture Partners, Sanderling Ventures, River Cities Capital Funds. In the next rounds fund is usually obtained by Silicon Valley Bank, MidCap Financial.
The fund has no exact preference in some founders of portfolio startups. Moreover, a startup needs to be at the age of 16-20 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight PerfectServe, Endocyte. Among the most popular fund investment industries, there are Health Care, Mobile.
The fund is generally included in less than 2 deals every year. The high activity for fund was in 2015. Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2011.
Investments analytics
Analytics
- Total investments
- 14
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.56
- Investments by industry
- Non Profit (10)
- Health Care (7)
- Education (6)
- Service Industry (4)
- Pharmaceutical (1) Show 6 more
- Investments by region
-
- United States (14)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 42
- Group Appearance index
- 0.14
- Avg. company exit year
- 22
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Endocyte | 19 Jan 2010 | Biotechnology, Health Care, Pharmaceutical | Late Stage Venture | 26M | United States, Indiana |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.